Anavex Life Sciences Reports Fiscal Second Quarter 2018 Financial Results

Anavex Life Sciences Reports Fiscal Second Quarter 2018 Financial Results  Conference Call and Webcast Today at 4:30 p.m. ET NEW YORK – May 10, 2018 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including Alzheimer’s disease, Rett…

Anavex Life Sciences to Announce Fiscal Second Quarter 2018 Financial Results on Thursday, May 10, 2018

Conference Call and Webcast To be Held Thursday, May 10, 2018 at 4:30pm Eastern Time  NEW YORK, NY – May 9, 2018 – Anavex Life Sciences Corp., (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases, including Alzheimer’s disease, Parkinson’s disease, Rett syndrome…